News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DSM Biomedical and Svelte Medical Systems, Inc. Execute License and Supply Agreement for DSM’s Proprietary Amino Acid Based–Drug Carrier for Svelte’s New All-in-One Drug-Eluting Stent System


11/7/2011 11:28:13 AM

BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM’s proprietary bioerodible amino acid based drug carrier in the design of a non-thrombogenic, non-inflammatory drug-eluting stent.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES